Akme Fintrade gets trading approval for 1.3 crore shares from exchanges
- Trading approval received from NSE and BSE for 1.3 crore equity shares
- Shares start trading on October 6, 2026
- Listed capital increases to ₹43,97,49,960
- Allotment made to non-promoters via warrant conversion
- Lock-in period ends on April 15, 2027
*this image is generated using AI for illustrative purposes only.
Akme Fintrade (India) Limited has received trading approval from the National Stock Exchange of India and BSE for 1.3 crore equity shares. The new shares will commence trading on October 6, 2026.
The approval covers equity shares with a face value of ₹1 each, allotted to non-promoters on a preferential basis pursuant to the conversion of warrants issued under Chapter V of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The regulatory nod was granted by both exchanges on October 5, 2026.
Impact on listed capital
Following the allotment and subsequent listing, the company's paid-up equity capital increased significantly. The total number of fully paid equity shares now stands at 43,97,49,960, resulting in a listed capital of ₹43,97,49,960.
The trading approval letters confirm that the securities are admitted to dealings on the respective exchanges effective Tuesday, October 6, 2026. The company filed the intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Share allotment details
The 1.3 crore shares were allotted in two distinct tranches, both subject to lock-in restrictions until April 15, 2027. The breakdown of the allotment is as follows:
| Tranche | Number of Shares | Issue Price Details | Distinctive Numbers Range |
|---|---|---|---|
| Tranche 1 | 30,00,000 | Premium of ₹10.10 | 426749961 to 429749960 |
| Tranche 2 | 1,00,00,000 | Premium of ₹7 | 429749961 to 439749960 |
All shares carry a face value of ₹1 each. The warrants were converted into equity shares, facilitating the increase in the company's shareholding base among non-promoter investors.
What the numbers show
The data reveals a divergence in the premium realized across the two tranches of warrant conversion. While the smaller tranche of 30 lakh shares was issued at a higher premium of ₹10.10 per share, the larger tranche of 1 crore shares carried a lower premium of ₹7 per share. This suggests that the conversion pricing varied between the two sets of warrants, potentially reflecting different entry valuations or issuance timelines prior to the final allotment.
Historical Stock Returns for Akme Fintrade
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.67% | +0.13% | -14.32% | -1.86% | -15.24% | -40.78% |
How might the significant dilution of existing shareholder equity impact Akme Fintrade's future earnings per share (EPS) metrics?
What specific strategic initiatives or debt reduction plans will the capital raised through these warrant conversions fund?
Could the April 2027 lock-in expiry trigger increased selling pressure on the stock price as non-promoter investors exit?
19
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
